Induction of Remission in RA Patients at Low Disease Activity by Additional Infliximab Therapy (Study P04644AM1) (TERMINATED)

Clinical trial NCT00521924 · TERMINATED

Trial details

NCT number: NCT00521924
Sponsor: Merck Sharp & Dohme LLC
Status: TERMINATED
Phase: Phase 3
Study type: INTERVENTIONAL

Rheumatoid Arthritis

Start date: 2007-06-01
Primary completion: 2008-04-01
Enrollment: 8

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.